OCUL
Price
$11.07
Change
+$0.31 (+2.88%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
1.71B
32 days until earnings call
VKTX
Price
$31.29
Change
+$0.89 (+2.93%)
Updated
Jul 10 closing price
Capitalization
3.41B
12 days until earnings call
Interact to see
Advertisement

OCUL vs VKTX

Header iconOCUL vs VKTX Comparison
Open Charts OCUL vs VKTXBanner chart's image
Ocular Therapeutix
Price$11.07
Change+$0.31 (+2.88%)
Volume$15.47K
Capitalization1.71B
Viking Therapeutics
Price$31.29
Change+$0.89 (+2.93%)
Volume$3.26M
Capitalization3.41B
OCUL vs VKTX Comparison Chart in %
Loading...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OCUL vs. VKTX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCUL is a Buy and VKTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (OCUL: $11.08 vs. VKTX: $31.29)
Brand notoriety: OCUL and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCUL: 117% vs. VKTX: 94%
Market capitalization -- OCUL: $1.71B vs. VKTX: $3.41B
OCUL [@Biotechnology] is valued at $1.71B. VKTX’s [@Biotechnology] market capitalization is $3.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCUL’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • OCUL’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both OCUL and VKTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCUL’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • OCUL’s TA Score: 4 bullish, 4 bearish.
  • VKTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both OCUL and VKTX are a good buy in the short-term.

Price Growth

OCUL (@Biotechnology) experienced а +15.18% price change this week, while VKTX (@Biotechnology) price change was +11.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

OCUL is expected to report earnings on Nov 10, 2025.

VKTX is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.41B) has a higher market cap than OCUL($1.71B). OCUL YTD gains are higher at: 29.742 vs. VKTX (-22.242). VKTX (-171.93M) and OCUL (-176.35M) have comparable annual earnings (EBITDA) . VKTX has more cash in the bank: 852M vs. OCUL (350M). VKTX has less debt than OCUL: VKTX (1M) vs OCUL (76.2M). OCUL has higher revenues than VKTX: OCUL (59.6M) vs VKTX (0).
OCULVKTXOCUL / VKTX
Capitalization1.71B3.41B50%
EBITDA-176.35M-171.93M103%
Gain YTD29.742-22.242-134%
P/E RatioN/AN/A-
Revenue59.6M0-
Total Cash350M852M41%
Total Debt76.2M1M7,620%
FUNDAMENTALS RATINGS
OCUL vs VKTX: Fundamental Ratings
OCUL
VKTX
OUTLOOK RATING
1..100
1411
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
43
Fair valued
PROFIT vs RISK RATING
1..100
8273
SMR RATING
1..100
9791
PRICE GROWTH RATING
1..100
4053
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (43) in the Biotechnology industry is in the same range as OCUL (55) in the Pharmaceuticals Other industry. This means that VKTX’s stock grew similarly to OCUL’s over the last 12 months.

VKTX's Profit vs Risk Rating (73) in the Biotechnology industry is in the same range as OCUL (82) in the Pharmaceuticals Other industry. This means that VKTX’s stock grew similarly to OCUL’s over the last 12 months.

VKTX's SMR Rating (91) in the Biotechnology industry is in the same range as OCUL (97) in the Pharmaceuticals Other industry. This means that VKTX’s stock grew similarly to OCUL’s over the last 12 months.

OCUL's Price Growth Rating (40) in the Pharmaceuticals Other industry is in the same range as VKTX (53) in the Biotechnology industry. This means that OCUL’s stock grew similarly to VKTX’s over the last 12 months.

OCUL's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as VKTX (100) in the Biotechnology industry. This means that OCUL’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OCULVKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 21 days ago
85%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RDWFX12.430.01
+0.08%
American Funds Dvlpg Wld Gr&Inc R5
GCEQX96.06N/A
N/A
Green Century Equity Individual Investor
HILTX22.78N/A
N/A
Hartford International Value R5
SRUIX14.44N/A
N/A
Meeder Spectrum Institutional
SOIUX20.56N/A
N/A
Spirit of America Utilts Inst

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+2.97%
EYPT - OCUL
58%
Loosely correlated
+0.91%
DNLI - OCUL
55%
Loosely correlated
+2.33%
NRIX - OCUL
52%
Loosely correlated
-3.87%
CRNX - OCUL
52%
Loosely correlated
-1.05%
RNA - OCUL
51%
Loosely correlated
+0.64%
More